Soligenix Shares Rise with Strategic Advisor Appointment

Soligenix shares are trading higher after the company announced the appointment of former White House Economic Adviser Tomas J. Philipson, PhD as a Strategic Advisor, enhancing the company's strategic initiatives as they advance their product candidate HyBryte™ in a Phase 3 clinical trial.